Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Skin substitutes & wound grafts · Tennessee | Skin substitutes & wound grafts · Florida | |
|---|---|---|
| Surgeons, 2024 | 38 | 307 |
| Medicare fee-for-service cases | 9,735 | 65,607 |
| Growth since 2019 (Medicare FFS) | +16%/yr | +28%/yr |
| Forecast cases (Medicare FFS) | 15,600 in 2030 | 135,200 in 2030 |
| Forecast growth | +8.1%/yr to 2030 | +13%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 8.3 | 16.8 |
| Medicare Advantage share | 57% | 60% |
| Out of hospital | 69% (+27 pts since 2019) | 81% (+45 pts since 2019) |
| Cases per surgeon | 256 | 214 |
| Top 10 surgeons' share | 56% | 14% |
| Surgeons growing | 3 | 14 |
| New since the base year | 29 | 237 |
| Likely to stop billing it | 21 by 2026 | 128 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $9,799 | $5,952 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.